ERBB2 and breast cancer: In aggregate, these data suggest that HRG induces activation of both MEK/MAPK and PI-3K/Akt signaling transduction pathways in mammary tumor cells with elevated expression levels of both the transgene rat c-neu/ErbB2 and the endogenous mouse ErbB3 gene.